Brokerages Anticipate Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Will Post Quarterly Sales of $606.01 Million

Wall Street brokerages forecast that Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Rating) will post sales of $606.01 million for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Acadia Healthcare’s earnings, with the lowest sales estimate coming in at $604.80 million and the highest estimate coming in at $607.90 million. Acadia Healthcare posted sales of $551.20 million during the same quarter last year, which would indicate a positive year over year growth rate of 9.9%. The business is expected to announce its next earnings report on Monday, January 1st.

On average, analysts expect that Acadia Healthcare will report full-year sales of $2.58 billion for the current financial year, with estimates ranging from $2.58 billion to $2.60 billion. For the next year, analysts anticipate that the company will report sales of $2.79 billion, with estimates ranging from $2.76 billion to $2.86 billion. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHCGet Rating) last issued its quarterly earnings results on Monday, February 28th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.68 by ($0.01). The company had revenue of $593.48 million for the quarter, compared to analyst estimates of $587.80 million. Acadia Healthcare had a return on equity of 9.66% and a net margin of 8.24%. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.13 EPS.

A number of equities research analysts recently issued reports on the company. StockNews.com assumed coverage on Acadia Healthcare in a research report on Thursday, March 31st. They set a “hold” rating on the stock. Credit Suisse Group raised their target price on Acadia Healthcare from $74.00 to $78.00 and gave the company an “outperform” rating in a report on Wednesday, March 2nd. Finally, SVB Leerink raised their target price on Acadia Healthcare from $80.00 to $90.00 and gave the company an “outperform” rating in a report on Friday, April 8th. One analyst has rated the stock with a sell rating, five have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $72.85.

Shares of NASDAQ:ACHC opened at $75.02 on Monday. The company has a market capitalization of $6.80 billion, a P/E ratio of 35.72, a P/E/G ratio of 2.43 and a beta of 1.40. Acadia Healthcare has a 1 year low of $50.07 and a 1 year high of $76.62. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.22 and a quick ratio of 1.22. The business’s 50 day simple moving average is $62.76 and its 200 day simple moving average is $59.87.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. Alliancebernstein L.P. boosted its holdings in shares of Acadia Healthcare by 1,503.4% during the 3rd quarter. Alliancebernstein L.P. now owns 2,176,689 shares of the company’s stock valued at $138,829,000 after acquiring an additional 2,040,937 shares in the last quarter. Ranger Global Real Estate Advisors LLC acquired a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $22,783,000. Invesco Ltd. boosted its holdings in shares of Acadia Healthcare by 132.5% during the 4th quarter. Invesco Ltd. now owns 1,598,040 shares of the company’s stock valued at $97,000,000 after acquiring an additional 910,813 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Acadia Healthcare by 136.4% during the 4th quarter. Millennium Management LLC now owns 928,206 shares of the company’s stock valued at $56,342,000 after acquiring an additional 535,593 shares in the last quarter. Finally, TD Asset Management Inc. boosted its holdings in shares of Acadia Healthcare by 103.1% during the 4th quarter. TD Asset Management Inc. now owns 856,000 shares of the company’s stock valued at $51,959,000 after acquiring an additional 434,500 shares in the last quarter.

Acadia Healthcare Company Profile (Get Rating)

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.

Featured Articles

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.